Testosterone Tied to Incidence, Progression of Metabolic Syndrome
By Lori Solomon HealthDay Reporter
THURSDAY, July 11, 2024 -- Testosterone is associated with a greater risk for development and progression of metabolic syndrome, particularly in transmasculine individuals, according to a study published online July 2 in JAMA Network Open.
Leila Hashemi, M.D., from the David Geffen School of Medicine in Los Angeles, and colleagues assessed whether gender-affirming hormone treatment (GAHT) by proxy steroid is associated with development and progression of metabolic syndrome. The analysis included 645 transgender participants and 645 matched cisgender participants.
The researchers found that metabolic syndrome z-scores changed significantly over time and differed significantly across groups. Transmasculine participants had the greatest percentage increase in mean z-scores after versus before the index GAHT date (298.0 percent), followed by cisgender females (108.3 percent), cisgender males (49.3 percent), and transfeminine persons (3.0 percent).
"In both cisgender and transgender individuals, estradiol was associated with reduced metabolic syndrome risk, whereas testosterone was associated with increased risk. These findings are relevant for the management of metabolic syndrome risk factors in cisgender and transgender individuals," the authors write. "It is also important to note that exogenous sex hormones are not equivalent to endogenous sex hormones, nor is the body in which they operate the same as one never exposed to the opposing sex hormones."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Testosterone Use Not Tied to Gynecological Cancers in Transmasculine Individuals
FRIDAY, May 16, 2025 -- Short-term testosterone use among transmasculine and gender diverse (TMGD) individuals is not associated with an increased risk for gynecological cancers...
General Practitioners Face Barriers to Treating Patients' Sexual Problems
MONDAY, May 12, 2025 -- While treating sexual problems is considered an important health care practice, general practitioners (GPs) report more barriers to caring for...
Hyperglycemia, Insulin Resistance in Teens Linked to Worsening Cardiac Damage at Age 24
FRIDAY, May 9, 2025 -- Adolescent hyperglycemia and worsening insulin resistance (IR) are associated with an increased risk for worsening structural and functional cardiac damage...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.